Should we treat severe sepsis with activated protein C?

Hosp Med. 2003 May;64(5):316. doi: 10.12968/hosp.2003.64.5.1771.
No abstract available

MeSH terms

  • Anti-Infective Agents / therapeutic use*
  • Clinical Trials as Topic
  • Decision Making
  • Humans
  • Protein C / therapeutic use*
  • Recombinant Proteins / therapeutic use*
  • Sepsis / drug therapy*

Substances

  • Anti-Infective Agents
  • Protein C
  • Recombinant Proteins
  • drotrecogin alfa activated